A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

NCT05926765 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands

Interventions

GENETIC: AAV2-hAQP1 Concentration 1
GENETIC: AAV2-hAQP1 Concentration 2
OTHER: Placebo
GENETIC: AAV2-hAQP1 Concentration 3
GENETIC: AAV2-hAQP1 Concentration 4

Sponsor

MeiraGTx, LLC